Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Epilepsia. 2017 Jan 18;58(2):239–246. doi: 10.1111/epi.13647

Table 1.

NAX 810-2 Efficacy in the Mouse Corneal Kindling Model Following IV Administration.

NAX 810-2 Dose (IV)
(mg/kg)		 Efficacy
(# protected / # tested)
0.2 1/7
0.5 3/7
0.75 10/12
3 6/7
ED50 (95% CI) 0.5 mg/kg (0.14 – 0.88)